Last viewed:
AZNCF
Prices are updated after-hours
AZNCF
|
$128.7
0
|
Health Technology
(0.0% 1d)
(-10.2% 1m)
(10.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(-36.24%
volume)
Earnings Calendar:
Market Cap: $ 199,273,287,856
http://astrazeneca.com
Sec
Filling
|
Patents
| n/a employees
(GB) AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
respiratory
urea
metabolic
cardiovascular
add to watch list
email alert is off
Press-releases
Fortress Biotech Announces Pricing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2023-02-08
(Crawled : 15:20)
- biospace.com/
FBIO
|
$0.7379
-11.63%
1.3M
|
Health Technology
| 0.0%
| O: -12.84%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| 0.0%
| O: 2.6%
H: 0.0%
C: 0.0%
offering
nasdaq
biotech
direct
Pulmonary Arterial Hypertension (PAH) Drugs Global Market 2022: Sector to Reach $9.4 Billion by 2027 at a CAGR of 5.29%
Published: 2023-02-03
(Crawled : 12:00)
- prnewswire.com
JNJ
|
$163.775
0.23%
1.8M
|
Health Technology
| -0.88%
| O: 1.7%
H: 0.0%
C: 0.0%
GSK
|
$36.375
0.57%
1.3M
|
Health Technology
| 1.55%
| O: -0.2%
H: 0.0%
C: 0.0%
UTHR
|
$253.35
-0.9%
68K
|
Health Technology
| -1.45%
| O: 0.59%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| 0.27%
| O: 0.47%
H: 0.0%
C: 0.0%
global
hypertension
market
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published: 2023-02-02
(Crawled : 14:20)
- globenewswire.com
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -0.06%
| O: -0.33%
H: 0.0%
C: 0.0%
ARTL
A
|
$3.0
7.5K
|
Health Technology
| -2.86%
| O: -1.27%
H: 0.0%
C: 0.0%
art27
treatment
cares
for
trial
art27.13
phase 2b
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published: 2023-02-02
(Crawled : 15:20)
- biospace.com/
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -0.06%
| O: -0.33%
H: 0.0%
C: 0.0%
ARTL
A
|
$3.0
7.5K
|
Health Technology
| -2.86%
| O: -1.27%
H: 0.0%
C: 0.0%
art27
treatment
cares
for
trial
art27.13
phase 2b
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Published: 2023-02-02
(Crawled : 15:00)
- biospace.com/
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -0.06%
| O: -0.33%
H: 0.0%
C: 0.0%
tezspire
for
approved
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published: 2023-01-31
(Crawled : 12:20)
- prnewswire.com
JNJ
|
$163.775
0.23%
1.8M
|
Health Technology
| -3.84%
| O: -3.75%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -4.25%
| O: -1.96%
H: 0.52%
C: 0.51%
growth
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published: 2023-01-30
(Crawled : 17:00)
- prnewswire.com
TAK
|
$16.125
1.29%
960K
|
Health Technology
| -1.43%
| O: -0.31%
H: 0.0%
C: 0.0%
PFE
|
$43.79
0.46%
5.8M
|
Health Technology
| -0.77%
| O: -0.79%
H: 0.0%
C: 0.0%
JNJ
|
$163.775
0.23%
1.8M
|
Health Technology
| -4.1%
| O: -0.26%
H: 0.0%
C: 0.0%
ABT
|
$110.75
-1.11%
830K
|
Health Technology
| 0.14%
| O: -0.59%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -2.86%
| O: 1.45%
H: 0.0%
C: 0.0%
global
report
gastrointestinal
therapeutics
market
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published: 2023-01-25
(Crawled : 03:00)
- prnewswire.com
GSK
|
$36.375
0.57%
1.3M
|
Health Technology
| 3.07%
| O: 0.26%
H: 0.0%
C: 0.0%
ABT
|
$110.75
-1.11%
830K
|
Health Technology
| -1.93%
| O: -2.56%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -3.92%
| O: -0.2%
H: 0.0%
C: 0.0%
america
for
growth
market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published: 2023-01-23
(Crawled : 13:00)
- biospace.com/
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -8.74%
| O: -1.28%
H: 0.57%
C: -1.6%
acquire
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18
(Crawled : 18:00)
- prnewswire.com
VTRS
|
$11.98
-1.07%
960K
|
Health Technology
| 1.77%
| O: -0.17%
H: 0.25%
C: -2.96%
TMO
|
$580.56
-0.44%
350K
|
Health Technology
| -2.59%
| O: 0.56%
H: 0.97%
C: -1.87%
NVO
|
$139.205
-0.28%
500K
|
Health Technology
| -0.41%
| O: 0.57%
H: 0.84%
C: -0.01%
NVS
|
$87.16
0.95%
730K
|
Health Technology
| -8.04%
| O: 0.08%
H: 0.01%
C: -1.16%
JNJ
|
$163.775
0.23%
1.8M
|
Health Technology
| -7.26%
| O: -1.47%
H: 0.0%
C: 0.0%
GSK
|
$36.375
0.57%
1.3M
|
Health Technology
| 1.15%
| O: -0.03%
H: 0.17%
C: -1.01%
LLY
M
|
$339.92
0.07%
570K
|
Health Technology
| -6.92%
| O: -1.13%
H: 0.0%
C: 0.0%
ABT
|
$110.75
-1.11%
830K
|
Health Technology
| -2.33%
| O: -0.16%
H: 0.33%
C: -1.5%
SNY
|
$47.58
1.3%
680K
|
Health Technology
| -7.1%
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB
A
|
$287.19
-1.46%
180K
|
Health Technology
| -0.45%
| O: 0.26%
H: 0.0%
C: 0.0%
AZN
|
$64.64
0.54%
2.2M
|
Health Technology
| -10.21%
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN
|
$241.38
-1.07%
870K
|
Health Technology
| -9.49%
| O: 0.0%
H: 0.41%
C: -1.87%
for
therapy
growth
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount